Outpatient pneumonia;Ausserhalb der klinik erworbene pneumonie

Praxis

Volumn 90, Issue 21, 2001, Pages 935-940

  Marrie, T J ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CEPHALOSPORIN DERIVATIVE; MACROLIDE; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE;

ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; CLINICAL FEATURE; DIAGNOSTIC APPROACH ROUTE; DISEASE ACTIVITY; DISEASE CLASSIFICATION; HUMAN; INCIDENCE; PENICILLIN RESISTANCE; PNEUMONIA; PROGNOSIS; RISK FACTOR;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; COMMUNITY-ACQUIRED INFECTIONS; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; INFANT; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PNEUMONIA, BACTERIAL; RESPIRATORY THERAPY; SWITZERLAND;

EID: 7444237193     PISSN: 16618157     EISSN: 16618165     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Rates of pneumonia during influenza epidemics in Seattle, 1964-1975
2. Pneumonia: An 11 year study in a pediatric practice
3. Lower respiratory tract illness in the first two years of life: Epidemiologic patterns and costs in a suburban pediatric practice
4. The epidemiology of community-acquired pneumonia among hospitalized adults
5. Incidence of community-acquired pneumonia in the population of four municipalities in eastern Finland
6. Risk factors for 30-day mortality in elderly patients with lower respiratory tract infection
7. Community-acquired pneumonia
8. Prognosis and outcomes of patients with community-acquired pneumonia: A meta-analysis
9. Outpatient treatment of community-acquired pneumonia in adults
10. Once-daily sparfloxacin versus high-dosage amoxicillin in the treatment of community-acquired, suspected pneumococcal pneumonia in adults
11. A multicenter, randomized study comparing the efficacy and safety of intravenous and/or oral levofloxacin versus ceftriaxone and/or cefuroxime axetil in treatment of adults with community-acquired pneumonia
12. Oral versus intravenous antibiotics for community-acquired lower respiratory tract infection in a general hospital: Open randomised controlled trial
13. A prospective randomized study of inpatient IV antibiotics for community-acquired pneumonia: The optimal duration of therapy
14. Early switch from intravenous antimicrobials to oral clarithromycin in patients with community acquired pneumonia
15. Bottle-blowing in hospital-treated patients with community-acquired pneumonia
16. Quality of care, process, and outcomes in elderly patients with pneumonia
17. Delay in appropriate therapy of legionella pneumonia associated with increased mortality
18. The efficacy of influenza vaccine in elderly persons: A meta-analysis and review of the literature
19. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community
20. The efficacy of influenza vaccination in elderly individuals: A randomized double-blind placebo-controlled trial
21. Protective efficacy of combined live intranasal and inactivated influenza A virus vaccines in the elderly
22. Influenza vaccination of health care workers in long-term-care hospitals reduces the mortality of elderly patients
23. Influenza virus
24. Efficacy of pneumococcal vaccination in adults: A meta-analysis of randomized controlled clinical trials
25. Randomised trial of 23-valent pneumococcal capsular polysaccharide vaccine in prevention of pneumonia in middle-aged and elderly people
26. Clinical efficacy of par pneumococcal vaccine in the elderly: A randomized, single-blind population-based trial
27. Magnitude, duration, quality and function of pneumococcal vaccine responses in elderly adults
28. Immunogenicity and impact on carriage of 9-valent pneumococcal conjugate vaccine given to infants in Soweto, South Africa
29. Streptococcus pneumoniae in human immunodeficiency virus type 1 infected children